title: Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance.
abstract: Mutations of the insulin receptor gene are a cause of the type A syndrome of extreme insulin resistance. This study assessed the prevalence of such mutations in women with clinical features of the type A syndrome including ovarian hyperandrogenism, moderate-to-severe degrees of insulin resistance, and acanthosis nigricans. We studied 22 unrelated women with insulin resistance (fasting insulin > 300 pM [50 microU/ml] and/or peak during an oral glucose tolerance test (OGTT) > 1,800 pM [300 microU/ml]), acanthosis nigricans, and the polycystic ovary syndrome (hyperandrogenemia, oligoamenorrhea, and hirsutism). Two insulin-resistant probands with congenital generalized lipodystrophy and one male proband with severe insulin resistance also were included in the study. Southern blotting experiments were performed to exclude gross gene deletions, insertions, or rearrangements. Exons 2-22 of the insulin receptor gene were polymerase chain reaction (PCR) amplified from genomic DNA and screened for nucleotide variation using single-strand conformation polymorphism (SSCP). No nucleotide variation between study subjects was detected in exons 4-6, 10-12, 15, 16, 18, 19, or 21. Sequencing of amplified DNA revealed that SSCP variants in exons 2, 3, 8, 9, and 17 corresponded to known silent polymorphisms within the coding region. Variants in exons 2, 9, 13, and 14 were caused by novel silent polymorphisms; variants in exons 7 and 22 were caused by nucleotide substitutions in flanking introns. One proband was found to have a heterozygous point mutation in exon 20 (CGG-->CAG, Arg1174-->Gln) that involves the intracellular receptor beta-subunit.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Charles A. Dana Research Institute, Boston, MA.
authors.forename: D E
authors.initials: DE
authors.lastname: Moller
authors.forename: O
authors.initials: O
authors.lastname: Cohen
authors.forename: Y
authors.initials: Y
authors.lastname: Yamaguchi
authors.forename: R
authors.initials: R
authors.lastname: Assiz
authors.forename: F
authors.initials: F
authors.lastname: Grigorescu
authors.forename: A
authors.initials: A
authors.lastname: Eberle
authors.forename: L A
authors.initials: LA
authors.lastname: Morrow
authors.forename: A C
authors.initials: AC
authors.lastname: Moses
authors.forename: J S
authors.initials: JS
authors.lastname: Flier
mesh_terms: D000052:Acanthosis Nigricans / Q000097:blood / Q000235:genetics*; D000293:Adolescent; D000328:Adult; D000595:Amino Acid Sequence; D001483:Base Sequence; D001786:Blood Glucose / Q000378:metabolism; D015139:Blotting, Southern; D002648:Child; D003062:Codon / Q000235:genetics; D005091:Exons; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007333:Insulin Resistance / Q000235:genetics*; D008060:Lipodystrophy / Q000235:genetics; D008297:Male; D017354:Point Mutation; D011085:Polycystic Ovary Syndrome / Q000097:blood / Q000235:genetics*; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D011972:Receptor, Insulin / Q000235:genetics*; D013577:Syndrome
chemical_list: D001786:Blood Glucose; D003062:Codon; D011972:Receptor, Insulin